Mechanisms · 2 min
Peptide half-life explained: what the number does—and does not—mean
Understand peptide half-life, the difference between in-vitro stability and human pharmacokinetics, and why half-life is not a dosing schedule.
The short version
A half-life value describes a measurement under particular conditions. It is not automatically the duration of an effect, a storage instruction, or a basis for a human dosing schedule.
Research use only. Educational reference to published literature—not medical advice or a guide to human use.
Half-life describes a decline in concentration
In common pharmacokinetic usage, half-life is the time for a measured blood or plasma concentration to decline by half. The reported value can depend on the phase of the concentration curve and the model used to describe it.
Do not read the number without its context. A terminal half-life, a laboratory degradation measurement, and a predicted stability estimate may all use the term 'half-life' while describing different observations. The cited pharmacokinetic overview explains the general concept rather than a particular peptide.
Sources: [1]
Laboratory stability is not human pharmacokinetics
Peptide stability in serum can be studied experimentally or modeled from sequence-related properties. Such research helps investigate degradation and design. It does not turn an in-vitro result or prediction into a measured human in-vivo half-life.
Distribution and clearance also affect concentrations in a living organism. A chemically modified peptide may behave differently from its unmodified counterpart. Keep the molecular form and measured compartment attached to the figure.
Sources: [2]
The route, species and assay all matter
Research on therapeutic peptides has examined metabolism at the injection site using an in-vitro analytical assay. This illustrates a broader interpretation issue: where and how a peptide is measured can influence what the result means. That assay is not a direct human terminal-half-life measurement.
Before comparing values, check species, formulation, route, sampling conditions, and analytical method. Figures collected under different conditions may answer different questions even if they share the same time unit.
Half-life is not the duration of effect
Concentration and biological effect are related but distinct observations. A downstream response may not follow the measured concentration curve exactly. Conversely, detecting material does not by itself show that a particular biological outcome is occurring.
This article deliberately does not convert half-life into timing instructions. Pharmacokinetic interpretation requires more than a single number, and a reference figure is not a recommendation for human use. Use the glossary and source papers to understand what was actually measured.
Sources: [1]
Sources & further reading
- 01The Practical Importance of Half-Life in Psychopharmacology (opens in a new tab)
- 02Estimating peptide half-life in serum from tunable, sequence-related physicochemical properties (opens in a new tab)
- 03A liquid chromatography high-resolution mass spectrometry in vitro assay to assess metabolism at the injection site of subcutaneously administered therapeutic peptides (opens in a new tab)